Global and Region Neuromodulation Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.

    The report details the trend, potential and market size of Neuromodulation market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Neuromodulationmarket, defines the market attractiveness level of Neuromodulation market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Neuromodulation industry, describes the types of Neuromodulation market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuromodulation market and the development prospects and opportunities of Neuromodulation industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuromodulation market in Chapter 13.

    By Player:

    • Medtronic, Inc

    • Nevro Corporation

    • Boston Scientific Corporation

    • Biocontrol Medical

    • Neurosigma, Inc

    • ST Jude Medical, Inc

    • Synapse Biomedical, Inc

    • Neuropace, Inc

    • Cyberonics, Inc

    • Neuronetics, Inc

    By Type:

    • Deep Brain Stimulation

    • Spinal Cord Stimulation

    • Transcranial Magnetic Stimulation

    By End-User:

    • Depression

    • Parkinson’s

    • Tinnitus

    • Alzheimer’s

    • Epilepsy

    • Ischemia

    • Obesity

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Neuromodulation Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Neuromodulation Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Neuromodulation Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Neuromodulation Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Neuromodulation Market Analysis and Outlook to 2022

    • 7.1 Global Neuromodulation Consumption (2017-2022)

    • 7.2 United States Neuromodulation Consumption (2017-2022)

    • 7.3 Europe Neuromodulation Consumption (2017-2022)

    • 7.4 China Neuromodulation Consumption (2017-2022)

    • 7.5 Japan Neuromodulation Consumption (2017-2022)

    • 7.6 India Neuromodulation Consumption (2017-2022)

    • 7.7 South Korea Neuromodulation Consumption (2017-2022)

    8 Region and Country-wise Neuromodulation Market Analysis and Outlook to 2028

    • 8.1 Global Neuromodulation Consumption Forecast (2022-2028)

    • 8.2 United States Neuromodulation Consumption Forecast (2022-2028)

    • 8.3 Europe Neuromodulation Consumption Forecast (2022-2028)

    • 8.4 China Neuromodulation Consumption Forecast (2022-2028)

    • 8.5 Japan Neuromodulation Consumption Forecast (2022-2028)

    • 8.6 India Neuromodulation Consumption Forecast (2022-2028)

    • 8.7 South Korea Neuromodulation Consumption Forecast (2022-2028)

    9 Global Neuromodulation Market Outlook by Types and Applications to 2022

    • 9.1 Global Neuromodulation Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Transcranial Magnetic Stimulation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neuromodulation Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Depression Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Parkinson’s Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Tinnitus Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Alzheimer’s Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Epilepsy Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Ischemia Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Obesity Consumption and Growth Rate (2017-2022)

    10 Global Neuromodulation Market Outlook by Types and Applications to 2028

    • 10.1 Global Neuromodulation Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Transcranial Magnetic Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Neuromodulation Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Depression Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Parkinson’s Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Tinnitus Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Alzheimer’s Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Ischemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    11 Global Neuromodulation Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Neuromodulation Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Neuromodulation Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Neuromodulation Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Neuromodulation Market Competitive Analysis

    • 14.1 Medtronic, Inc

      • 14.1.1 Medtronic, Inc Company Details

      • 14.1.2 Medtronic, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medtronic, Inc Neuromodulation Product and Service

    • 14.2 Nevro Corporation

      • 14.2.1 Nevro Corporation Company Details

      • 14.2.2 Nevro Corporation Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nevro Corporation Neuromodulation Product and Service

    • 14.3 Boston Scientific Corporation

      • 14.3.1 Boston Scientific Corporation Company Details

      • 14.3.2 Boston Scientific Corporation Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Boston Scientific Corporation Neuromodulation Product and Service

    • 14.4 Biocontrol Medical

      • 14.4.1 Biocontrol Medical Company Details

      • 14.4.2 Biocontrol Medical Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biocontrol Medical Neuromodulation Product and Service

    • 14.5 Neurosigma, Inc

      • 14.5.1 Neurosigma, Inc Company Details

      • 14.5.2 Neurosigma, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Neurosigma, Inc Neuromodulation Product and Service

    • 14.6 ST Jude Medical, Inc

      • 14.6.1 ST Jude Medical, Inc Company Details

      • 14.6.2 ST Jude Medical, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 ST Jude Medical, Inc Neuromodulation Product and Service

    • 14.7 Synapse Biomedical, Inc

      • 14.7.1 Synapse Biomedical, Inc Company Details

      • 14.7.2 Synapse Biomedical, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Synapse Biomedical, Inc Neuromodulation Product and Service

    • 14.8 Neuropace, Inc

      • 14.8.1 Neuropace, Inc Company Details

      • 14.8.2 Neuropace, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Neuropace, Inc Neuromodulation Product and Service

    • 14.9 Cyberonics, Inc

      • 14.9.1 Cyberonics, Inc Company Details

      • 14.9.2 Cyberonics, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Cyberonics, Inc Neuromodulation Product and Service

    • 14.10 Neuronetics, Inc

      • 14.10.1 Neuronetics, Inc Company Details

      • 14.10.2 Neuronetics, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Neuronetics, Inc Neuromodulation Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Neuromodulation

    • Figure Neuromodulation Picture

    • Table Global Neuromodulation Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuromodulation Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Neuromodulation Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Neuromodulation Consumption by Country (2017-2022)

    • Figure United States Neuromodulation Consumption and Growth Rate (2017-2022)

    • Table Europe Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure China Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Japan Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure India Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neuromodulation Consumption and Growth Rate (2017-2022)

    • Figure Global Neuromodulation Consumption Forecast by Country (2022-2028)

    • Figure United States Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neuromodulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Brain Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Cord Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Transcranial Magnetic Stimulation Consumption and Growth Rate (2017-2022)

    • Figure Global Depression Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson’s Consumption and Growth Rate (2017-2022)

    • Figure Global Tinnitus Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer’s Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Ischemia Consumption and Growth Rate (2017-2022)

    • Figure Global Obesity Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Brain Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spinal Cord Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transcranial Magnetic Stimulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Depression Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson’s Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tinnitus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer’s Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ischemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Obesity Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Neuromodulation Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Neuromodulation Export by Region (Top 5 Countries) (2017-2028)

    • Table Medtronic, Inc (Foundation Year, Company Profile and etc.)

    • Table Medtronic, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic, Inc Neuromodulation Product and Service

    • Table Nevro Corporation (Foundation Year, Company Profile and etc.)

    • Table Nevro Corporation Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nevro Corporation Neuromodulation Product and Service

    • Table Boston Scientific Corporation (Foundation Year, Company Profile and etc.)

    • Table Boston Scientific Corporation Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Scientific Corporation Neuromodulation Product and Service

    • Table Biocontrol Medical (Foundation Year, Company Profile and etc.)

    • Table Biocontrol Medical Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocontrol Medical Neuromodulation Product and Service

    • Table Neurosigma, Inc (Foundation Year, Company Profile and etc.)

    • Table Neurosigma, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurosigma, Inc Neuromodulation Product and Service

    • Table ST Jude Medical, Inc (Foundation Year, Company Profile and etc.)

    • Table ST Jude Medical, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table ST Jude Medical, Inc Neuromodulation Product and Service

    • Table Synapse Biomedical, Inc (Foundation Year, Company Profile and etc.)

    • Table Synapse Biomedical, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synapse Biomedical, Inc Neuromodulation Product and Service

    • Table Neuropace, Inc (Foundation Year, Company Profile and etc.)

    • Table Neuropace, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuropace, Inc Neuromodulation Product and Service

    • Table Cyberonics, Inc (Foundation Year, Company Profile and etc.)

    • Table Cyberonics, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cyberonics, Inc Neuromodulation Product and Service

    • Table Neuronetics, Inc (Foundation Year, Company Profile and etc.)

    • Table Neuronetics, Inc Neuromodulation Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neuronetics, Inc Neuromodulation Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.